FLGT (STOCKS)
Fulgent Genetics, Inc. Common Stock
$18.650000
-0.060000 (-0.32%)
Prev close: $18.710000
Company Information
- Exchange
- XNAS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Ming Hsieh
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $544.92M
- Employees
- 1,313
- P/E (TTM)
- -6.61
- P/B (TTM)
- 0.51
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $323.93M |
| Benefits Costs and Expenses | $416.38M |
| Cost Of Revenue | $208.67M |
| Costs And Expenses | $416.38M |
| Gross Profit | $115.26M |
| Nonoperating Income/Loss | $29.83M |
| Operating Expenses | $237.55M |
| Research and Development | $56.76M |
| Other Operating Expenses | $180.79M |
| Operating Income/Loss | -$122.28M |
| Income/Loss From Continuing Operations After Tax | -$85.47M |
| Income/Loss From Continuing Operations Before Tax | -$92.45M |
| Income Tax Expense/Benefit | -$6.98M |
| Income Tax Expense/Benefit, Deferred | -$2.18M |
| Net Income/Loss | -$85.47M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$1.09M |
| Net Income/Loss Attributable To Parent | -$84.38M |
| Net Income/Loss Available To Common Stockholders, Basic | -$84.38M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Average Shares | 89,704,000 |
| Diluted Average Shares | 89,704,000 |
| Assets | $1.09B |
| Current Assets | $454.77M |
| Inventory | $793.00K |
| Prepaid Expenses | $4.98M |
| Other Current Assets | $449.00M |
| Noncurrent Assets | $634.45M |
| Fixed Assets | $113.07M |
| Intangible Assets | $149.26M |
| Other Non-current Assets | $372.13M |
| Liabilities | $93.24M |
| Current Liabilities | $71.76M |
| Accounts Payable | $15.56M |
| Other Current Liabilities | $56.20M |
| Noncurrent Liabilities | $21.48M |
| Equity | $995.99M |
| Equity Attributable To Noncontrolling Interest | -$5.63M |
| Equity Attributable To Parent | $1.00B |
| Liabilities And Equity | $1.09B |
| Net Cash Flow From Operating Activities | -$83.70M |
| Net Cash Flow From Operating Activities, Continuing | -$83.70M |
| Net Cash Flow From Investing Activities | $91.98M |
| Net Cash Flow From Investing Activities, Continuing | $91.98M |
| Net Cash Flow From Financing Activities | -$70.04M |
| Net Cash Flow From Financing Activities, Continuing | -$70.04M |
| Exchange Gains/Losses | $181.00K |
| Net Cash Flow | -$61.58M |
| Net Cash Flow, Continuing | -$61.76M |
| Comprehensive Income/Loss | -$89.15M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$689.00K |
| Comprehensive Income/Loss Attributable To Parent | -$88.46M |
| Other Comprehensive Income/Loss | -$3.68M |